Sign In
Buy CTLT
$63.49
+0 (+0%)
At Close: Mar 14, 2025
Catalent, Inc. (CTLT) Q4 2022 Earnings Call Transcript
01:16pm, Monday, 29'th Aug 2022
Catalent, Inc. (NYSE:CTLT ) Q4 2022 Earnings Conference Call August 29, 2022 9:15 AM ET Company Participants Paul Surdez – Vice President-Investor Relations Alessandro Maselli – President and Chie
Catalent (CTLT) Q4 Earnings Beat Estimates, Revenues Lag
12:47pm, Monday, 29'th Aug 2022
Catalent's (CTLT) robust performance across most of its segments drives its fourth-quarter fiscal 2022 top line.
Catalent (CTLT) Q4 Earnings Surpass Estimates
09:47am, Monday, 29'th Aug 2022
Catalent (CTLT) delivered earnings and revenue surprises of 3.48% and 0.89%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Catalent Sees Drop in Covid-Related Product Revenue in 2023
09:40am, Monday, 29'th Aug 2022
The shares of Catalent Inc (NYSE:CTLC) are down 1.7% at $98 this morning, following the pharmaceutical company's fiscal fourth-quarter earnings report.
These Are The 10 Biggest Companies Releasing Earnings Next Week
08:19pm, Thursday, 25'th Aug 2022
Earnings per share (EPS) growth of S&P 500 companies so far this week has remained almost unchanged from last week and is at the lowest level since the fourth quarter of 2020.
A Trio of Companies Growing Earnings Fast
03:13pm, Sunday, 21'st Aug 2022
The S&P 500 saw the annual real earnings per share of its member companies increase by an average growth rate of 19.6% every year over the past five years ending in December 2021. The index, which sto
Catalent: No Catalyst Just Yet
03:19pm, Wednesday, 10'th Aug 2022
Catalent has built up a solid track record of value creation over the past nearly decade long period. The company has seen excellent operating momentum, despite the pandemic being on its retreat.
Catalent, Inc. Announces Fourth Quarter Fiscal Year 2022 Earnings Conference Webcast
08:50am, Friday, 05'th Aug 2022
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, the leading global provider of advanced delivery technologies, development, manufacturing and clinical supply solutions for drugs, biologics, cell and gene t
ASRT vs. CTLT: Which Stock Is the Better Value Option?
12:47pm, Thursday, 04'th Aug 2022
ASRT vs. CTLT: Which Stock Is the Better Value Option?
Catalent: Primary Packaging Capability Expansion To Drive Growth
08:38am, Thursday, 04'th Aug 2022
The expansion of primary packaging capabilities in Japan is expected to drive significant growth for Catalent in coming years. Recently, Catalent announced a new operating structure in which the compa
Watch These Leaders With Earnings Due, Buy Zones In Focus
01:11pm, Monday, 01'st Aug 2022
With earnings due, IBD Leaderboard stocks like Eli Lilly, Vertex and Ollie's test bases, breakouts and buy zones. The post Watch These Leaders With Earnings Due, Buy Zones In Focus appeared first on I
5 Real Growth 'Strong Buys'
12:15pm, Monday, 01'st Aug 2022
The Seeking Alpha Quant system has its quirks, but it is a great tool to find great holdings. I typically dredge through the weeds to find unique situations that may be unloved by the quant system.
A Technical Look at Catalent Stock After Last Week's Big Update
01:39pm, Tuesday, 12'th Jul 2022
Catalent Inc (NYSE:CTLT) is a multinational company that enables pharma, biotech, and consumer health partners to optimize product development, launch, and supply of treatments for patients around the
Catalent (CTLT) Expands Packaging Capabilities at Japan Facility
12:29pm, Thursday, 30'th Jun 2022
Catalent's (CTLT) latest capability expansion is expected to boost its business in this key hub in its Asia-Pacific Clinical Supply Services network.
3 Reasons to Retain Catalent (CTLT) Stock in Your Portfolio
02:42pm, Wednesday, 29'th Jun 2022
Catalent's (CTLT) robust facility expansion activities and a slew of strategic deals raise optimism about the stock.
